Skip to Main Content
LuminUltra
EnglishFrançais简体中文
LuminUltra Technologies Ltd.

Introducing our complete COVID-19 clinical solution

LuminUltra Technologies Ltd. is proud to announce that we’ve submitted our GeneCount® COVID-19 RT-qPCR Assay Kit to the U.S. Food and Drug Administration for Emergency Use Authorization and Health Canada for an Interim Order.

With this authorization we’ll be able to provide testing facilities throughout North America with a complete, customizable clinical COVID-19 testing solution.

Everything you need from one trusted company

With the authorization of the GeneCount® COVID-19 RT-qPCR Assay Kit, LuminUltra will be able to offer flexibility to testing facilities around the world by providing some or all of the necessary COVID-19 testing components from a single, reputable company.

Facilities can onboard additional testing capacity more quickly, without the need to source components from multiple suppliers. We’re a proven supply chain, as a key supplier of the isolation reagents to the Government of Canada since April, providing 500,000 tests/week to their national testing program.

“Human diagnostic testing for COVID-19 has scaled up very quickly and has become complicated for facilities. We hear frustration as users are forced to source inflexible components for testing from different companies and work through supply chain issues since these products are in high-demand – all while trying to provide safe testing solutions for patients,” says LuminUltra Chairman and CEO Pat Whalen.

Flexible solutions

“We have been working relentlessly to provide flexible solutions – all from one company with a proven track record of meeting demand.”

Facilities can select GeneCount® COVID-19 testing devices based on their needs and size, from portable, qPCR testing devices that can assess up to 16 samples in under two hours, to large format, high-capacity and automated qPCR and extraction devices.

Biological testing expertise

LuminUltra has a history of biological testing innovation. Alongside the clinical diagnostic test, we’ve created GeneCount® Environmental Monitoring Solutions – an onsite environmental surveillance system that detects the presence of SARS-CoV-2, the virus that causes COVID-19, on surfaces, in the air, or in wastewater within two hours.

The environmental test allows corporations, building managers, hotels, cruise ship operators, service providers and others to verify disinfection protocols as well as pinpoint potential asymptomatic and presymptomatic carriers. The GeneCount® qPCR devices – both the portable and high-capacity options – also process the environmental test, providing a holistic approach to pandemic management.

What’s included?

Our accurate GeneCount® COVID-19 RT-qPCR Testing Solution includes multiple components to make up an end-to-end solution, including:

• sample collection kits;
• isolation kits
• the COVID-19 Assay; and
• a range of quick-detection qPCR testing devices with software for simple interpretation of COVID-19 test results with confidence in under two hours.

Learn more

LuminUltra has a range of reliable, fast, and sensitive testing solutions to identify the presence of COVID-19 and SARS-CoV-2.

Contact us to learn more about a testing protocol to meet your needs.


LuminUltra Team

Founded in 1995, LuminUltra is a molecular biology diagnostic testing company headquartered in Canada with operations in 6 countries. It is widely recognized globally as a leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring applications and is a key supplier of COVID-19 diagnostic testing reagents to the Government of Canada.

Dozens of Fortune 500 customers across more than 80 countries trust LuminUltra’s technology, production reliability and history of customer service excellence to deliver their essential services in a safe state.

Related Posts

LuminUltra Headquarters

#MadeInCanada: How COVID-19 shaped our business

It has been one year since Canadian Prime Minister, Justin Trudeau announced that LuminUltra would be supplying the federal government with reagent for 25 million COVID-19 clinical diagnostic tests. Having now fulfilled our commitment, we wanted to take this opportunity to reflect on the past year and what it’s meant for our LuminUltra team. When… Read More

All you need to know about qPCR

Updated January 2021 You may have heard of quantitative Polymerase Chain Reaction (qPCR) in the news recently as the gold-standard testing method for COVID-19. But did you know that this technology can be used to test for harmful organisms in industrial processes? Identifying the presence of invasive and potentially damaging organisms in industrial processes can… Read More

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now